Literature DB >> 6830670

Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.

P H Kay, A Capuani, R Franks, C Lincoln.   

Abstract

Between June 1978 and January 1982, 115 patients underwent 122 subclavian artery-pulmonary artery shunts using polytetrafluoroethylene (PTFE Impra) grafts. Forty-six of the patients had a ductus dependent pulmonary circulation, the patency of which was maintained by an infusion of prostaglandin E2 in 29 cases. There were nine hospital deaths, four of which were related to shunt failure. Five patients underwent a second shunt procedure within one week of the first. There were two cases of late graft occlusion. Twelve shunts were considered to have failed. The actuarial estimate of shunt patency was 90% (+/- 3%) at two years for all patients and 74% (+/- 10%) for neonates. There was no statistically significant difference in two year shunt patency between 4 mm grafts (88 +/- 5%) and 6 mm grafts (96 +/- 3%). The modified Blalock shunt using a PTFE graft is an effective pulmonary-systemic shunt with a good short term patency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830670      PMCID: PMC481313          DOI: 10.1136/hrt.49.4.359

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  13 in total

1.  Prevention of platelet aggregation and adherence to prosthetic vascular grafts by aspirin and dipyridamole.

Authors:  R W Oblath; F O Buckley; R M Green; S I Schwartz; J A DeWeese
Journal:  Surgery       Date:  1978-07       Impact factor: 3.982

2.  The effects of ligation of the subclavian artery on the bones and soft tissues of the arms.

Authors:  G Currarino; M A Engle
Journal:  J Pediatr       Date:  1965-11       Impact factor: 4.406

3.  Arterial prosthesis of microporous expanded polytetrafluoroethylene for construction of aorta-pulmonary shunts.

Authors:  A B Gazzaniga; J J Lamberti; R D Siewers; D R Sperling; W R Dietrick; R A Arcilla; R L Replogle
Journal:  J Thorac Cardiovasc Surg       Date:  1976-09       Impact factor: 5.209

4.  Aorta-pulmonary artery shunts with expanded polytetrafluoroethylene (PTFE) tube.

Authors:  K Miyamoto; C Zavanella; A N Lewin; S Subramanian
Journal:  Ann Thorac Surg       Date:  1979-05       Impact factor: 4.330

5.  The use of prostaglandin E1 and Blalock-Taussig shunts in neonates with cyanotic congenital heart disease.

Authors:  D A Browdie; W Norberg; R Agnew; B Altenburg; R Ignacio; C Hamilton
Journal:  Ann Thorac Surg       Date:  1979-06       Impact factor: 4.330

6.  Staged surgical management of tetralogy of Fallot in infants.

Authors:  L W Stephenson; S Friedman; L H Edmunds
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

7.  Routine primary repair vs two-stage repair of tetralogy of Fallot.

Authors:  J W Kirklin; E H Blackstone; A D Pacifico; R N Brown; L M Bargeron
Journal:  Circulation       Date:  1979-08       Impact factor: 29.690

8.  Medical manipulation of the ductus arteriosus.

Authors:  R B Elliott; M B Starling; J M Neutze
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

9.  Use of microporous expanded polytetrafluoroethylene grafts for aorta-pulmonary shunts in infants with complex cyanotic heart disease. A report of seven cases.

Authors:  R B Jennings; B J Innes; R D Brickman
Journal:  J Thorac Cardiovasc Surg       Date:  1978-10       Impact factor: 5.209

10.  Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.

Authors:  M R de Leval; R McKay; M Jones; J Stark; F J Macartney
Journal:  J Thorac Cardiovasc Surg       Date:  1981-01       Impact factor: 5.209

View more
  11 in total

1.  Balloon dilatation of a stenosed modified (polytetrafluoroethylene) Blalock-Taussig shunt.

Authors:  J M Parsons; E J Ladusans; S A Qureshi
Journal:  Br Heart J       Date:  1989-09

2.  Modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.

Authors:  S E Greenwald; C L Berry; P H Kay; R E Franks; A Capuani; C Lincoln
Journal:  Br Heart J       Date:  1984-11

3.  Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt.

Authors:  Mehmet Küçük; Rahmi Özdemir; Mustafa Karaçelik; Önder Doksöz; Cem Karadeniz; Yılmaz Yozgat; Timur Meşe; Nejat Sarıosmanoğlu
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

4.  Shots and shunts.

Authors:  A Davidson; L A Marks
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

5.  Growth of the pulmonary artery after neonatal balloon dilatation of the right ventricular outflow tract in an infant with the tetralogy of Fallot and atrioventricular septal defect.

Authors:  J M Parsons; E J Ladusans; S A Qureshi
Journal:  Br Heart J       Date:  1989-07

6.  Tetralogy of Fallot.

Authors:  Samantha C. Gouw; Thuy-Nga Le; Narayanswami Sreeram
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10

7.  Pulmonary balloon valvuloplasty in the palliation of complex cyanotic congenital heart disease.

Authors:  O Stümper; J F Piéchaud; P Bonhoeffer; D Bonnet; Y Aggoun; D Sidi; J Kachaner
Journal:  Heart       Date:  1996-10       Impact factor: 5.994

8.  Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study.

Authors:  S A Qureshi; C R Kirk; R K Lamb; R Arnold; J L Wilkinson
Journal:  Br Heart J       Date:  1988-09

9.  Recanalisation of an occluded modified Blalock-Taussig shunt by balloon dilatation.

Authors:  N Sreeram; K Walsh; I Peart
Journal:  Br Heart J       Date:  1993-11

10.  Septic involvement of polytetrafluoroethylene (PTFE) anastomoses producing false aneurysms: diagnosis and problems related to management.

Authors:  C N Monarrez; R F Montalvo; V R Conti; D W Sapire
Journal:  Pediatr Cardiol       Date:  1984       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.